The management of ascites using the Rhodiascit Apparatus ("Paris Pump").
The Rhodiascit Apparatus ("Paris Pump") which ultrafilters sodium and water from ascitic fluid allowing reinfusion of a protein-rich concentrate, has been found to be a valuable procedure in the management of ascites associated with liver cirrhosis. The device was evaluated in eight patients with the aim of rapidly controlling ascites with minimum hospitalisation. The duration of the procedure varied from 8.5 to 55 hr (mean 27 hr) and resulted in a mean girth reduction of 13 cm (range 5.7 to 24 cm) and a mean weight loss of 13.6 kg (range 5.7 to 23 kg). Serum electrolytes and total protein were unchanged; a slight but insignificant rise in serum creatinine was observed. Three infective episodes occurred, but these were easily controlled. The procedure was, in general, well tolerated, inexpensive and allowed rapid relief of ascites with few complications.
D000328:Adult; D000368:Aged; D001201:Ascites / Q000628:therapy*; D001798:Blood Proteins; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000032:analysis / Q000097:blood; D011506:Proteins / Q000032:analysis; D012964:Sodium / Q000032:analysis / Q000097:blood; D014462:Ultrafiltration / Q000295:instrumentation*
D001798:Blood Proteins; D011506:Proteins; D012964:Sodium; D011188:Potassium